Journal of Pharmacology and Pharmacotherapeutics volume 12, issue 1 cover
Search this issue

Cover: Journal of Pharmacology and Pharmacotherapeutics

Journal of Pharmacology and Pharmacotherapeutics

Volume 12, Issue 1

2021 · pp. 1–28 · 6 articles

Volume
12
Issue
1
Published
2021
Pages
1–28
Articles
6
Sections
4
ISSN
Print - 0976-500X, Online - 0976-5018
Journal
JPP

In this issue

Research Paper

  1. Article

    Omaimah Toufiq, Syed Wasif Gillani, Farhanah Mohamed, Nafis Pasha, Muhsina Chiraparambil, Affana Parveen

    pp. 1–9 · DOI: 10.4103/jpp.JPP_154_20 · 2021

    Objective: To compare the safety and efficacy of linagliptin with pioglitazone in combination therapy of metformin for the management of type 2 diabetes mellitus (T2DM). Materials and Methods: A meta‑analayis research de…

  2. Article

    Sonali Opneja, Shirley Ann D Souza, Roopesh Sureshan, Pabitra Ghoshal

    pp. 10–13 · DOI: 10.4103/jpp.JPP_163_20 · 2021

    Objective: To compare the efficacy and side effects of 5HT3 antagonists, ramosetron, and ondansetron as prophylaxis for postoperative nausea and vomiting (PONV) following general anesthesia. Materials and Methods: One hu…

  3. Article

    Aarya Jitendra Kshirsagar, Yogita Karandikar, Leena Phadake

    pp. 14–19 · DOI: 10.4103/jpp.JPP_166_20 · 2021

    Objective: To observe the effect of statins on cardiac autonomic neuropathy in patients with diabetes and to study the correlation between cardiac autonomic neuropathy as assessed by cardiac autonomic reflex tests (CARTs…

Research Letter

  1. Article

    Sharan Shyam, Sanjay Jaiswal

    pp. 20–22 · DOI: 10.4103/jpp.JPP_156_20 · 2021

Case Report

  1. Article

    Nidheesh Chooriyil, Doyce Jom, Prabitha Panattil, Syam Sreedharan

    pp. 23–25 · DOI: 10.4103/jpp.JPP_157_20 · 2021

    Protamine is a routinely used safe antidote for heparin reversal in cardiovascular surgeries. Protamine was first introduced to prolong the action of insulin preparations. As protamine interacts with platelets and fibrin…

Review Article

  1. Review

    Merin Babu, Keechilat Pavithran

    pp. 26–28 · DOI: 10.4103/jpp.jpp_170_20 · 2021

    Androgen deprivation therapy (ADT) is currently the mainstay of treatment for advanced prostate cancer. The peptide formulations of gonadotropin‑releasing hormone (GnRH) antagonists need to be given subcutaneously every …